Projects per year
Personal profile
Education
- 國立成功大學 公衛所 博士
- 國立成功大學 醫學系 學士
Experience
- 2013年08月 ~ 迄今 成大醫院胸腔內科醫師
- 2011年08月 ~ 2013年07月 成大醫院斗六分院胸腔內科醫師
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Szu-Chun Yang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Finished
-
Estimating the Cost-Effectiveness of Taiwan Lung Cancer Screening in Neversmoker Trial (Talent)
Yang, S.-C. (PI)
22-08-01 → 23-07-31
Project: Research project
-
-
Comparative Cost-Effectiveness of Three First-Line Therapies for Egfr-Mutated Advanced Nsclc--Constructing a Cost-Effectiveness Estimating Platform
Yang, S.-C. (PI)
18-08-01 → 19-07-31
Project: Research project
-
Cost-Effectiveness Analysis of Low-Dose Computed Tomographic Screening for Lung Cancer in Taiwan
Yang, S.-C. (PI)
15-08-01 → 16-07-31
Project: Research project
-
BPI25-005: Molecular Biomarker Testing Patterns and Turn-Around Time in US Patients With Advanced Non-Small Cell Lung Cancer
Wang, X., Lee, D., Yang, S. C., Li, Y., Soulos, P. R., Gross, C. P., Wang, S. Y. & Chiang, A. C., 2025 Mar 28, In: Journal of the National Comprehensive Cancer Network : JNCCN. 23, 35Research output: Contribution to journal › Article › peer-review
-
Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung Adenocarcinoma
Ou, H. T., Tsai, J. H., Chen, Y. L., Wu, T. I., Chen, L. J. & Yang, S. C., 2025 Apr, In: PharmacoEconomics. 43, 4, p. 429-440 12 p., e2200201.Research output: Contribution to journal › Article › peer-review
-
Cost-effectiveness of lazertinib as first-line treatment in patients with EGFR-mutated advanced lung cancer
Ku, L. J. E., Tsai, J. H., Chen, L. J. & Yang, S. C., 2025 Jan 1, In: Therapeutic Advances in Medical Oncology. 17Research output: Contribution to journal › Article › peer-review
Open Access -
Effective prevention in clinical practice may save human capital loss: Real-world evidence from Taiwan's National Health Insurance
Wang, F., Huang, W. Y., Chang, Y. T., Yang, S. C. & Wang, J. D., 2024 Nov, In: Journal of the Formosan Medical Association. 123, p. S251-S258Research output: Contribution to journal › Review article › peer-review
Open Access -
Estimating Costs Associated with Adverse Events in Patients with Advanced Lung Cancer
Lin, C. Y., Wu, T. I. & Yang, S. C., 2024, In: ClinicoEconomics and Outcomes Research. 16, p. 761-769 9 p.Research output: Contribution to journal › Article › peer-review
Open Access